Share
Journal Information
Most often read
9202
SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppressionJairo Cajamarca-Baron, Diana Guavita-Navarro, Jhon Buitrago-Bohorquez, Laura Gallego-Cardona, Angela Navas, Hector Cubides, Ana María Arredondo, Alejandro Escobar, Adriana Rojas-Villarraga
Reumatol Clin. 2021;17:408-19
9202
Open Article
9163
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumabLuis Figuero-Pérez, Alejandro Olivares-Hernández, Roberto A. Escala-Cornejo, Eduardo Terán-Brage, Álvaro López-Gutiérrez, Juan J. Cruz-Hernández
Reumatol Clin. 2021;17:559-61
9163
Open Article
9004
Gouty Involvement of Foot and Ankle: Beyond FlaresJosé-Antonio Bernal, Jonatan García-Campos, Javier Marco-LLedó, Mariano Andrés
Reumatol Clin. 2021;17:106-12
9004
Open Article
8338
Temporal arteritis in a young patient. A clinical caseSilvia Blanco-Alonso, Susana Mellor-Pita, Fernando Alfageme, Laura Najera Botella, Pedro Duran-Campo, Pablo Tutor-Ureta
Reumatol Clin. 2021;17:297-9
8338
Open Article
7542
Therapeutic options for the management of severe COVID-19: A rheumatology perspectiveClaudia Mendoza-Pinto, Mario García-Carrasco, Pamela Munguía Realpozo, Socorro Méndez-Martínez
Reumatol Clin. 2021;17:431-6
7542
Open Article
6205
Hip pain secondary to intermuscular lipomaFrancisco Vílchez-Oya, Tarek Carlos Salman-Monte, Jordi Monfort
Reumatol Clin. 2021;17:175-7
6205
Open Article
5786
Systematic review of the impact of drugs on diffuse interstitial lung disease associated with rheumatoid arthritisCarmen Carrasco Cubero, Eugenio Chamizo Carmona, Paloma Vela Casasempere
Reumatol Clin. 2021;17:504-13
5786
Open Article
5711
Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patientsGiovanni Montealegre-Gómez, Edgar Garavito, Arley Gómez-López, Adriana Rojas-Villarraga, Rafael Parra-Medina
Reumatol Clin. 2021;17:371-5
5711
Open Article
5045
Clinical impact of nailfold capillaroscopy in daily clinical practiceLuis A. Torrens Cid, Christian Y. Soleto K, María Montoro-Álvarez, Claudia Sáenz Tenorio, Alicia Silva-Riveiro, Ana López-Cerón, Ana M. Anzola Alfaro, Liz Rocío Caballero Motta, ... Juan Carlos Nieto-González
Reumatol Clin. 2021;17:258-62
5045
Open Article
4909
COVID-19: Overview of rheumatology fellowsAndrea Garcia-Guillén, Sicylle Jeria, David Lobo-Prat, Luís Sainz
Reumatol Clin. 2021;17:491-3
4909
Open Article
4705
Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018Mario H. Cardiel, Sandra Carrillo, Marcela Pérez, Lilia Andrade, César Pacheco Tena, Luis H. Silveira, Leonardo Limón, Sergio Cerpa, ... Daniel Xibillé Friedmann
Reumatol Clin. 2021;17:215-28
4705
Open Article
4698
Is “Joker” syndrome a distinctive characteristic of neuro-Behçet's diseaseGerardo Toantiu Jaimes-Piñon, Ildefonso Rodrìguez-Leyva, Carlos Abud Mendoza
Reumatol Clin. 2021;17:368-9
4698
Open Article
4449
Recommendations of the Mexican College of Rheumatology for the management of spondyloarthritisGreta Reyes-Cordero, Favio Enríquez-Sosa, Citlallyc Gomez-Ruiz, Verónica Gonzalez-Diaz, José Dionisio Castillo-Ortiz, Sergio Duran-Barragán, J. Santos Duran-Ortiz, Rolando Espinosa-Morales, ... Ruben Burgos-Vargas
Reumatol Clin. 2021;17:37-45
4449
Open Article
4288
Pericarditis and pericardial effusion in a patient with tophaceous gout. Infection or complication due to deposit of microcrystals?Marta Novella-Navarro, Luis Sala-Icardo, Alejandro Prada-Ojeda
Reumatol Clin. 2021;17:241
4288
Open Article
4200
A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritisAlberto Jiménez-Morales, Rafael Cáliz, Susana Aceituno, Miriam Prades, Carles Blanch
Reumatol Clin. 2021;17:536-42
4200
Open Article
4109
Subclinical interstitial lung disease in patients with systemic sclerosis. A pilot study on the role of ultrasoundSamuel Reyes-Long, Marwin Gutierrez, Denise Clavijo-Cornejo, Alfonso Alfaro-Rodríguez, Karen González-Sámano, José Luis Cortes-Altamirano, Roberto Muñoz-Louis, Esteban Cruz-Arenas, ... Chiara Bertolazzi
Reumatol Clin. 2021;17:144-9
4109
Open Article
4080
Pneumocystis jirovecii in immunocompromised patients with rheumatic diseasesPaloma Vela Casasempere, Paloma Ruiz Torregrosa, Raquel García Sevila
Reumatol Clin. 2021;17:290-6
4080
Open Article
3983
Tolosa-Hunt syndrome as an initial presentation of sarcoidosisAnahy Brandy-García, Carlos Suárez-Cuervo, Luis Caminal-Montero
Reumatol Clin. 2021;17:178-9
3983
Open Article
3951
Validation of the HAQ-UP-A (Health Assessment Questionnaire-Upper Limbs-Argentine Version) in patients with rheumatoid arthritisJuan Manuel Bande, Silvia Beatriz Papasidero, María Alejandra Medina, María Julia Santa Cruz, Diana Silvia Klajn, José Angel Caracciolo, Julieta Giantinoto, Florencia Pelagagge, María Gabriela Battaglia
Reumatol Clin. 2021;17:20-4
3951
Open Article
3937
Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemic lupus erythematosus in SpainIñigo Rúa-Figueroa Fernández de Larrinoa, José María Pego-Reigosa
Reumatol Clin. 2021;17:245-9
3937
Open Article
Special content about COVID-19
- Spontaneous pneumomediastinum: An extra muscular manifestation of anti-MDA5 dermatomyositis. Report of 2 cases
- The impact of COVID-19 and other factors on the usage status of the biologic drug therapies for rheumatoid arthritis: A study from Vietnam
- Analysis of factors involved in the development of humoral response to vaccination against SARS-CoV-2 in patients with rheumatic pathology under biological treatment
- The “autoimmune/inflammatory syndrome induced by adjuvants” (ASIA) after COVID-19 infection: A case report
Publish in
Reumatología Clínica